The international business exhibition, organized by the Indian Pharmaceutical Association (IPA) concurrent to the third IPA convention has evoked enormous response among the global pharmaceutical industry. The convention, which commenced on September 14, 2003 in Mumbai, is mainly focusing on the global opportunities for Indian pharma industry.
The convention, with the theme “Destination India – Global Pharma Business”, offered a unique opportunity to Indian pharma companies to interact with their counterparts in the world. Indian companies involved in business related pharmaceutical field such as contract research, machinery, software development participated in the convention.
“The interaction revolved around the technical and commercial requirements, regulations in export markets, level of technology expertise and costs. In the currently changing global pharmaceutical scenario, the convention provides a platform for ‘Buyers and Sellers’ of all countries to display their capabilities and source products. Similarly, this can attract Contract Research Projects for Indian and the expected business generation could be to the tune of Rs. 500 crore” said Subodh Priolkar, the Chairman of the Convention.
Techno-commercial strategy for marketing in developed countries by Gautam Kumra, Prinicpal, McKinsey & Company, India; cGMPs for 21st Century by Dr Vinod Shah, President, American Association of Pharmaceutical Scientist (AAPS) USA; Advancement in Pharmaceutical Technology by Dr Hari Fluora, President of operations Applied Containment Engg, USA; Counterfeiting- International perspective by Dr Michael Anisfeld, Globepharm, USA; Opportunities-Target India by Dr Denis Croisat, Director, API outsourcing, Aventis Pharma, Germany; Clinical Trials: Opportunities in clinical research and contract research in India by Dr Mohan Beltangady, Vice President, Global Research& Development, Pfizer Inc, USA was covered during the scientific programme on September 15, 2003.
International companies like Aventis, Asta Inc, USA, Ratiopharma, Merck, Globepharm, Pfizer, M.J.H. International, Pharmascience Inc with many leading Indian companies participated in the convention and exhibition.